Position in TNGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$80,053,706
+$33,285,488 QoQ
Shares Held
3,826,659
-27.5% QoQ
Ownership
2.65%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Balyasny Asset Management L.P. holds $2,162,763,632 across 176 Biotechnology names. TNGX ranks #3 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
2,779,445 | $146,532,340 | |
| 2 | ERAS |
Erasca, Inc.
|
5,143,985 | $83,229,677 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
This page
|
3,826,659 | $80,053,706 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
1,917,501 | $77,141,065 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,362,752 | $76,981,860 | |
| 6 | CYTK |
Cytokinetics Inc
|
992,545 | $65,418,640 | |
| 7 | DAWN |
Day One Biopharmaceuticals, Inc.
|
2,625,235 | $56,285,038 | |
| 8 | FOLD |
AMICUS THERAPEUTICS, INC.
|
3,827,513 | $55,345,837 |
All Filings in TNGX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $80,053,706 | 3,826,659 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $46,768,218 | 5,278,580 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $29,166,538 | 3,472,207 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $16,627,010 | 3,247,463 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,410,812 | 3,219,571 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,132,715 | 3,279,196 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $20,691,409 | 2,687,196 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,376,737 | 277,009 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $9,507,685 | 844,377 | Shares | Sole | 2023-11-14 | |
| 2022-03-31 | $240,899 | 31,781 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||